Central Bank & Trust’s Chemours CC Stock Holding History

Central Bank & Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30	Closed	–	–	320
2016 Q1	$0	Hold	30	–	–	﹤0.01%	351
2015 Q4	$0	Hold	30	–	–	﹤0.01%	361
2015 Q3	$0	Buy	+30	New	+$314	﹤0.01%	389

Other funds holding CC

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Central Bank & Trust's CC Position: Q2 2016 in Review

Central Bank & Trust sold out of Chemours (CC) in Q2 2016, closing a stake of 30 shares.

Central Bank & Trust first reported a position in CC in Q3 2015 and held it in 3 quarters. The position peaked at $0 in Q1 2016. 371 funds tracked by Wall St. Rank hold CC as of Q2 2016.

Central Bank & Trust reported no remaining Chemours position as of Q2 2016 after selling out during the quarter.
Central Bank & Trust sold 30 Chemours shares in Q2 2016.
Central Bank & Trust first reported a position in Chemours in Q3 2015 and held it in 3 quarters.
Central Bank & Trust's Chemours position peaked at $0 in Q1 2016.
371 funds tracked by Wall St. Rank held Chemours as of Q2 2016.

Based on Central Bank & Trust's 13F filing for Q2 2016, filed 11 Jul 2016.